시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 마이크로바이옴 시퀀싱 서비스 시장 보고서(2025년)
Microbiome Sequencing Service Global Market Report 2025
상품코드 : 1855924
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,684,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,662,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,639,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

마이크로바이옴 시퀀싱 서비스 시장 규모는 최근 급속도로 확대되고 있습니다. 2024년 20억 7,000만 달러에서 2025년에는 24억 3,000만 달러에 달하고, CAGR 17.3%로 확대될 전망입니다. 과거 조사기간 내 성장의 원동력은 인간 미생물총 연구에 대한 관심 증가, 소화기 질환의 유병률의 상승, 항생제 내성에 대한 의식의 고조, 질환 진단에 있어서의 마이크로바이옴 연구의 광범위한 이용, 연구 기관간의 협력 관계의 강화 등입니다.

마이크로바이옴 시퀀싱 서비스 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 CAGR 16.9%로 45억 4,000만 달러로 성장할 전망입니다. 예측기간 내 성장은 정밀영양학에 대한 주목 고조, 마이크로바이옴 기반의 치료제에 대한 수요 증가, 예방의료에 대한 소비자의 관심 증가, 신약 개발에서의 마이크로바이옴 데이터의 이용 확대, 임상 현장에서의 마이크로바이옴 검사의 폭넓은 채용에 의해 발생할 것으로 예측됩니다. 예측 기간의 주요 동향은 메타유전체 시퀀싱 방법의 발전, 마이크로바이옴 기반 진단 솔루션 개발, 데이터 분석을 위한 바이오인포매틱스 도구의 발전, 멀티오믹스 접근법의 통합 성장, 맞춤 마이크로바이옴 치료의 출현 등을 포함합니다.

장 관련 질환의 유병률 증가는 마이크로바이옴 시퀀싱 서비스 시장의 성장을 가속화할 것으로 예측됩니다. 장 관련 질환이란 위, 장, 간 및 췌장과 같은 관련 기관을 포함한 위장관(GI)에 영향을 미치는 질환을 말합니다. 이러한 질병의 이환율 상승은 장 내 세균총의 균형을 어지럽히는 가공식품의 소비 증가와 식이섬유 섭취량의 감소 등의 라이프스타일과 식생활의 변화에 기인하고 있습니다. 마이크로바이옴 시퀀싱 서비스는 장내 미생물의 조성에 대한 자세한 인사이트를 제공함으로써 이러한 질병의 관리를 지원하고 소화기 질환의 진단 및 모니터링에 필수적입니다. 이러한 서비스는 미생물의 불균형을 확인하는 데 도움이 되며, 맞춤 치료 및 전반적인 장의 건강 관리를 개선하는 표적 개입을 가능하게 합니다. 예를 들어, 2025년 6월 영국 보건안전청은 2022년과 2024년 사이에 캄필로박터 감염자가 인구 10만 명당 96.1명에서 122명으로 27.0% 증가했다고 보고했습니다. 따라서, 장 관련 질환의 유병률 증가가 마이크로바이옴 시퀀싱 서비스 시장의 확대에 기여하고 있습니다.

마이크로바이옴 시퀀싱 서비스 시장의 주요 기업은 메타게노믹 시퀀싱 기술과 같은 고급 자동화 솔루션의 개발에 주력하고 있습니다. 이러한 자동화 시스템은 최소한의 수작업으로 미생물 커뮤니티의 시퀀싱 및 분석을 가능하게 하여 높은 정확도, 반복성 및 확장 가능한 처리량을 보장합니다. 예를 들어, 2024년 7월 MGI Tech Co., Ltd.는 인간 마이크로바이옴 군유전체학 시퀀싱 패키지를 출시했습니다. 이 완전 통합 시스템은 자동화된 샘플 전처리, 핵산 추출, 라이브러리 준비, 시퀀싱 및 데이터 분석을 결합하여 비용 효율적인 고처리량 마이크로바이옴 연구를 지원합니다. 수많은 인간 대변 샘플에서 검증된 성능은 재현성과 정확성을 보장하며 대규모 인간 마이크로바이옴 연구의 새로운 표준을 제시합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

CSM
영문 목차

영문목차

A microbiome sequencing service is a specialized scientific process that examines the genetic material of microbial communities found in biological or environmental samples such as the gut, skin, or soil. It is applied to identify, measure, and describe microorganisms in order to gain insights into their composition, diversity, and functional roles.

The core components of microbiome sequencing include sample preparation, sequencing and library preparation, and data analysis. Sample preparation focuses on processing collected biological material to maintain quality and purity for sequencing. The technologies used include sequencing by ligation, sequencing by synthesis, shotgun sequencing, targeted gene sequencing, RNA sequencing, and others. These services are utilized in fields such as autoimmune disorders, cancer, and gastrointestinal disorders, supporting end users such as pharmaceutical and biotechnology companies, academic institutions, and research organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The microbiome sequencing service market research report is one of a series of new reports from The Business Research Company that provides microbiome sequencing service market statistics, including microbiome sequencing service industry global market size, regional shares, competitors with a microbiome sequencing service market share, detailed microbiome sequencing service market segments, market trends and opportunities, and any further data you may need to thrive in the microbiome sequencing service industry. This microbiome sequencing service market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The microbiome sequencing service market size has grown rapidly in recent years. It will grow from $2.07 billion in 2024 to $2.43 billion in 2025 at a compound annual growth rate (CAGR) of 17.3%. Growth during the historic period was driven by increased interest in human microbiota research, higher prevalence of gastrointestinal disorders, greater awareness of antibiotic resistance, wider use of microbiome studies in disease diagnostics, and stronger collaborations among research institutions.

The microbiome sequencing service market size is expected to see rapid growth in the next few years. It will grow to $4.54 billion in 2029 at a compound annual growth rate (CAGR) of 16.9%. Growth in the forecast period is expected to result from the rising emphasis on precision nutrition, increasing demand for microbiome-based therapeutics, stronger consumer focus on preventive healthcare, expanding use of microbiome data in drug discovery, and broader adoption of microbiome testing in clinical settings. Key trends for the forecast period include progress in metagenomic sequencing methods, development of microbiome-based diagnostic solutions, advancements in bioinformatics tools for data analysis, growth in the integration of multi-omics approaches, and the emergence of personalized microbiome-based therapies.

The increasing prevalence of gut-related diseases is expected to drive the growth of the microbiome sequencing service market. Gut-related diseases refer to conditions affecting the gastrointestinal (GI) tract, including the stomach, intestines, and other associated organs such as the liver and pancreas. The rising incidence of these diseases can be attributed to lifestyle and dietary changes, such as increased consumption of processed foods and reduced fiber intake, which disrupt the balance of gut microbiota. Microbiome sequencing services aid in the management of these diseases by providing detailed insights into the composition of gut microbes, making it crucial for diagnosing and monitoring gastrointestinal conditions. These services help identify microbial imbalances, enabling targeted interventions that improve personalized treatment and overall gut health management. For example, in June 2025, the UK Health Security Agency reported a 27.0% increase in Campylobacter cases, from 96.1 to 122.0 per 100,000 population, between 2022 and 2024. As a result, the growing prevalence of gut-related diseases is contributing to the expansion of the microbiome sequencing service market.

Key companies in the microbiome sequencing service market are focusing on developing advanced automated solutions, such as metagenomics sequencing technologies. These automated systems enable the sequencing and analysis of microbial communities with minimal manual intervention, ensuring high accuracy, reproducibility, and scalable throughput. For instance, in July 2024, MGI Tech Co. Ltd., a biotechnology company based in China, launched the Human Microbiome Metagenomics Sequencing Package. This fully integrated system combines automated sample pretreatment, nucleic acid extraction, library preparation, sequencing, and data analysis, supporting high-throughput and cost-efficient microbiome research. Its validated performance on a large number of human stool samples ensures reproducibility and accuracy, setting a new standard for large-scale human microbiome studies.

In May 2025, Mapmygenome India Limited, a genomics and diagnostics company based in India, acquired Microbiome Insights Inc. to expand its microbiome sequencing and analysis capabilities. This acquisition aims to strengthen Mapmygenome's presence in the North American market and enhance its offerings in personalized health, genomics, and research services. Microbiome Insights Inc., based in Canada, specializes in microbiome sequencing services.

Major players in the microbiome sequencing service market are Eurofins Scientific LLC, Illumina Inc., Charles River Laboratories, QIAGEN N.V., Merieux NutriSciences Corporation, OraSure Technologies Inc., Zifo RnD Solutions, Novogene Co. Ltd., Oxford Nanopore Technologies Plc, Macrogen Inc., Zymo Research Corporation, CD Genomics, Molzym GmbH & Co. KG (Gradian Diagnostics), Baseclear BV, Psomagen Inc., Mapmygenome, Rancho Biosciences LLC, Boster Biological Technology Ltd., Clinical Microbiomics, and Microba Life Sciences Limited.

North America was the largest region in the microbiome sequencing service market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in microbiome sequencing service report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the microbiome sequencing service market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The microbiome sequencing service market includes revenues earned by entities through microbiome biomarker discovery, host-microbiome interaction analysis, microbial strain identification, metatranscriptomic profiling, metaproteomic analysis, metabolomic profiling, microbiome-based diagnostics development, and microbiome therapeutics support services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Microbiome Sequencing Service Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on microbiome sequencing service market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for microbiome sequencing service ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The microbiome sequencing service market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Microbiome Sequencing Service Market Characteristics

3. Microbiome Sequencing Service Market Trends And Strategies

4. Microbiome Sequencing Service Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Microbiome Sequencing Service Growth Analysis And Strategic Analysis Framework

6. Microbiome Sequencing Service Market Segmentation

7. Microbiome Sequencing Service Market Regional And Country Analysis

8. Asia-Pacific Microbiome Sequencing Service Market

9. China Microbiome Sequencing Service Market

10. India Microbiome Sequencing Service Market

11. Japan Microbiome Sequencing Service Market

12. Australia Microbiome Sequencing Service Market

13. Indonesia Microbiome Sequencing Service Market

14. South Korea Microbiome Sequencing Service Market

15. Western Europe Microbiome Sequencing Service Market

16. UK Microbiome Sequencing Service Market

17. Germany Microbiome Sequencing Service Market

18. France Microbiome Sequencing Service Market

19. Italy Microbiome Sequencing Service Market

20. Spain Microbiome Sequencing Service Market

21. Eastern Europe Microbiome Sequencing Service Market

22. Russia Microbiome Sequencing Service Market

23. North America Microbiome Sequencing Service Market

24. USA Microbiome Sequencing Service Market

25. Canada Microbiome Sequencing Service Market

26. South America Microbiome Sequencing Service Market

27. Brazil Microbiome Sequencing Service Market

28. Middle East Microbiome Sequencing Service Market

29. Africa Microbiome Sequencing Service Market

30. Microbiome Sequencing Service Market Competitive Landscape And Company Profiles

31. Microbiome Sequencing Service Market Other Major And Innovative Companies

32. Global Microbiome Sequencing Service Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Microbiome Sequencing Service Market

34. Recent Developments In The Microbiome Sequencing Service Market

35. Microbiome Sequencing Service Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기